Trade Mark Journal No.2026/038 18 September 2026

WO0000001934995 (5,42)

Office of origin: United States of America

Date of International Registration:24 June 2026
Date of designation in the UK: 24 June 2026
Image for mark 1934995 SENVI

International priority date claimed: 5 January 2026 (United States of America) (99578651)
Class 5
Pharmaceutical products and preparations for the treatment of cancer and aging-related diseases; synthetic peptides for the treatment of cancer and aging-related diseases.
Class 42
Pharmaceutical, scientific, and medical research and development services; pharmaceutical products development; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development in the field of pharmaceuticals.

Senvi Inc.

Representative: Delfina S. Homen Miller Nash LLP, 1140 SW Washington St., Ste. 700, Portland OR 97205, UNITED STATES OF AMERICA